Fiera Capital (Canada)
NVCR icon

Fiera Capital (Canada)’s NovoCure NVCR Stock Holding History

Fiera Capital (Canada)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,192
Closed -$257K – 516
2023
Q4 		$257K Sell
17,192
-320
-2% -$4.28K ﹤0.01% 479
2023
Q3 		$283K Hold
17,512
– – ﹤0.01% 465
2023
Q2 		$727K Hold
17,512
– – ﹤0.01% 381
2023
Q1 		$1.05M Sell
17,512
-307,118
-95% -$24.5M ﹤0.01% 356
2022
Q4 		$23.8M Sell
324,630
-6,745
-2% -$508K 0.07% 134
2022
Q3 		$23.1M Sell
331,375
-5,659
-2% -$441K 0.08% 132
2022
Q2 		$23.4M Sell
337,034
-5,590
-2% -$421K 0.07% 139
2022
Q1 		$28.4M Buy
342,624
+46
+0% +$3.39K 0.07% 145
2021
Q4 		$25.7M Sell
342,578
-19,181
-5% -$1.93M 0.06% 158
2021
Q3 		$42M Sell
361,759
-5,573
-2% -$843K 0.11% 106
2021
Q2 		$81.5M Sell
367,332
-10,026
-3% -$1.95M 0.21% 62
2021
Q1 		$49.9M Sell
377,358
-8,151
-2% -$1.29M 0.14% 92
2020
Q4 		$66.7M Buy
385,509
+2,623
+0.7% +$359K 0.18% 76
2020
Q3 		$42.6M Sell
382,886
-12,850
-3% -$1.03M 0.13% 100
2020
Q2 		$23.5M Sell
395,736
-10,211
-3% -$672K 0.08% 156
2020
Q1 		$27.3M Buy
405,947
+173,680
+75% +$13.7M 0.11% 118
2019
Q4 		$19.6M Buy
232,267
+187,313
+417% +$15.1M 0.07% 170
2019
Q3 		$3.36M Sell
44,954
-6,141
-12% -$491K 0.01% 278
2019
Q2 		$3.23M Sell
51,095
-2,578
-5% -$131K 0.01% 309
2019
Q1 		$2.58M Sell
53,673
-23,868
-31% -$1.15M 0.01% 348
2018
Q4 		$2.6M Buy
+77,541
New +$2.84M 0.01% 354

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fiera Capital (Canada)'s NVCR Position: Q1 2024 in Review

Fiera Capital (Canada) sold out of NovoCure (NVCR) in Q1 2024, closing a stake of 17,192 shares — an estimated $257K sold.

Fiera Capital (Canada) first reported a position in NVCR in Q4 2018 and held it in 21 quarters. The position peaked at $81.5M in Q2 2021. 238 funds tracked by Wall St. Rank hold NVCR as of Q1 2024.

  • Fiera Capital (Canada) reported no remaining NovoCure position as of Q1 2024 after selling out during the quarter.
  • Fiera Capital (Canada) sold 17,192 NovoCure shares in Q1 2024, an estimated $257K.
  • Fiera Capital (Canada) first reported a position in NovoCure in Q4 2018 and held it in 21 quarters.
  • Fiera Capital (Canada)'s NovoCure position peaked at $81.5M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held NovoCure as of Q1 2024.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2024, filed 1 May 2024.